Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P28
Within normal range
vs 3Y Ago
-3.6x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.67% |
| Q3 2025 | -48.78% |
| Q2 2025 | 10.87% |
| Q1 2025 | -2.22% |
| Q4 2024 | -87.50% |
| Q3 2024 | 29.41% |
| Q2 2024 | -25.93% |
| Q1 2024 | 10.00% |
| Q4 2023 | -42.86% |
| Q3 2023 | -10.53% |
| Q2 2023 | -58.33% |
| Q1 2023 | 65.71% |
| Q4 2022 | 5.41% |
| Q3 2022 | 21.28% |
| Q2 2022 | 4.08% |
| Q1 2022 | 2.00% |
| Q4 2021 | 45.65% |
| Q3 2021 | -16.46% |
| Q2 2021 | -3.95% |
| Q1 2021 | 14.61% |
| Q4 2020 | -39.06% |
| Q3 2020 | 47.11% |
| Q2 2020 | -68.06% |
| Q1 2020 | -9.09% |
| Q4 2019 | 29.79% |
| Q3 2019 | -135.00% |
| Q2 2019 | -26566.67% |
| Q1 2019 | 99.97% |
| Q4 2018 | -9.98% |
| Q3 2018 | 28.15% |
| Q2 2018 | 1.21% |
| Q1 2018 | -21.38% |
| Q4 2017 | -4.15% |
| Q3 2017 | 5.95% |
| Q2 2017 | -2.31% |
| Q1 2017 | -24.61% |
| Q4 2016 | 28.86% |
| Q3 2016 | 2.54% |
| Q2 2016 | 15.36% |
| Q1 2016 | 24.83% |